newsfilter
← Latest News
GlobeNewswire·

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference

BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that